It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The extent of microglial heterogeneity in humans remains a central yet poorly explored question in light of the development of therapies targeting this cell type. Here, we investigate the population structure of live microglia purified from human cerebral cortex samples obtained at autopsy and during neurosurgical procedures. Using single cell RNA sequencing, we find that some subsets are enriched for disease-related genes and RNA signatures. We confirm the presence of four of these microglial subpopulations histologically and illustrate the utility of our data by characterizing further microglial cluster 7, enriched for genes depleted in the cortex of individuals with Alzheimer’s disease (AD). Histologically, these cluster 7 microglia are reduced in frequency in AD tissue, and we validate this observation in an independent set of single nucleus data. Thus, our live human microglia identify a range of subtypes, and we prioritize one of these as being altered in AD.
Imbalance of microglial phenotypes in the aging brain might underlie their involvement in late onset neurodegenerative diseases. Here we report the population structure of microglia in the aged human brain and the reduction of a particular microglia subset in individuals with Alzheimer’s disease .
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details












1 Columbia University Medical Center, Center for Translational and Computational Neuroimmunology, New York, USA (GRID:grid.239585.0) (ISNI:0000 0001 2285 2675); Columbia University Medical Center, Taub Institute for Research on Alzheimer’s Disease and Aging Brain, New York, USA (GRID:grid.239585.0) (ISNI:0000 0001 2285 2675); Columbia University Medical Center, Department of Neurology, New York, USA (GRID:grid.239585.0) (ISNI:0000 0001 2285 2675); Broad Institute, Cell Circuits Program, Cambridge, USA (GRID:grid.66859.34)
2 Broad Institute, Cell Circuits Program, Cambridge, USA (GRID:grid.66859.34); The Hebrew University of Jerusalem, Edmond & Lily Safra Center for Brain Sciences, Jerusalem, Israel (GRID:grid.9619.7) (ISNI:0000 0004 1937 0538)
3 Columbia University Medical Center, Center for Translational and Computational Neuroimmunology, New York, USA (GRID:grid.239585.0) (ISNI:0000 0001 2285 2675)
4 Columbia University Medical Center, Taub Institute for Research on Alzheimer’s Disease and Aging Brain, New York, USA (GRID:grid.239585.0) (ISNI:0000 0001 2285 2675); Columbia University Medical Center, Department of Pathology and Cell Biology, New York, USA (GRID:grid.239585.0) (ISNI:0000 0001 2285 2675)
5 University of Freiburg, Institute of Neuropathology, Medical Faculty, Freiburg, Germany (GRID:grid.5963.9); University of Freiburg, Berta-Ottenstein-Programme for Clinician Scientists, Faculty of Medicine, Freiburg, Germany (GRID:grid.5963.9)
6 Max-Planck-Institute of Immunobiology and Epigenetics, Freiburg, Germany (GRID:grid.429509.3) (ISNI:0000 0004 0491 4256)
7 Broad Institute, Cell Circuits Program, Cambridge, USA (GRID:grid.66859.34)
8 Brigham and Women’s Hospital, Department of Neurology, Boston, USA (GRID:grid.62560.37) (ISNI:0000 0004 0378 8294)
9 Brigham and Women’s Hospital, Department of Neurosurgery, Boston, USA (GRID:grid.62560.37) (ISNI:0000 0004 0378 8294)
10 Brigham and Women’s Hospital, Department of Pathology, Boston, USA (GRID:grid.62560.37) (ISNI:0000 0004 0378 8294)
11 University of Freiburg, Institute of Neuropathology, Medical Faculty, Freiburg, Germany (GRID:grid.5963.9); University of Freiburg, Signaling Research Centers BIOSS and CIBSS, Freiburg, Germany (GRID:grid.5963.9); University of Freiburg, Center for NeuroModulation, Faculty of Medicine, Freiburg, Germany (GRID:grid.5963.9)
12 Columbia University Medical Center, Taub Institute for Research on Alzheimer’s Disease and Aging Brain, New York, USA (GRID:grid.239585.0) (ISNI:0000 0001 2285 2675); Columbia University Medical Center, Department of Neurology, New York, USA (GRID:grid.239585.0) (ISNI:0000 0001 2285 2675); Columbia University Medical Center, Department of Pathology and Cell Biology, New York, USA (GRID:grid.239585.0) (ISNI:0000 0001 2285 2675)
13 Rush University Medical Center, Rush Alzheimer’s Disease Center, Chicago, USA (GRID:grid.240684.c) (ISNI:0000 0001 0705 3621)
14 Broad Institute, Cell Circuits Program, Cambridge, USA (GRID:grid.66859.34); Broad Institute of MIT and Harvard, Klarman Cell Observatory, Cambridge, USA (GRID:grid.66859.34); Department of Biology, MIT, Howard Hughes Medical Institute, Cambridge, USA (GRID:grid.116068.8) (ISNI:0000 0001 2341 2786); Genentech, 1 DNA Way, South San Francisco, USA (GRID:grid.418158.1) (ISNI:0000 0004 0534 4718)
15 Columbia University Medical Center, Taub Institute for Research on Alzheimer’s Disease and Aging Brain, New York, USA (GRID:grid.239585.0) (ISNI:0000 0001 2285 2675); Columbia University Medical Center, Department of Neurology, New York, USA (GRID:grid.239585.0) (ISNI:0000 0001 2285 2675); Broad Institute, Cell Circuits Program, Cambridge, USA (GRID:grid.66859.34)